Currently viewing the tag: "Spectrum"
After a hectic day – its time for a little soulsearching. I have no shares in TopoTarget, but that’s just a coincidence, I might as well have had; but basically I am always a little wary with “one-trick-pony’s “- especially biotech-ponies –
Relying on just one product-line is dangerous, it’s 100% make/break … But after todays […]
I have made an update on the Spectrum Chart.
Pay attention to the blue line at $15, it could be, that $15 proves to be an area where there is major resistance !!
This is TopoTarget at a glance, hopefully this will provide you with an overview of one of the most exiting Biotech companies in Denmark.
Apart from telling you a bit about the investment-opportunity, I (investor89) will also make a laymans explanation of some the abbreviations you will encounter when studying TopoTarget
TopoTarget themselves describe the […]
Being a Danish investor I first learned about Spectrum Pharmaceuticals back in 2010, when Spectrum and Danish TopoTarget entered into an agreement on HDACi inhibitor Belinostat.
After having read extensively about the possibilities of Spectrum I decided to make a investment in 2010, at the time the stock was trading in the 4-5 dollar range. Today […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard
